Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.62 |
| ▸ | PLCD1 | P51178 | 1/20 | 0.55 |
| ▸ | CNR1 | P21554 | 3/20 | 0.54 |
| ▸ | CA12 | O43570 | 1/20 | 0.53 |
| ▸ | CA1 | P00915 | 1/20 | 0.53 |
| ▸ | CA2 | P00918 | 1/20 | 0.53 |
| ▸ | CA9 | Q16790 | 1/20 | 0.53 |
| ▸ | F2 | P00734 | 1/20 | 0.53 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.53 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.53 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.53 |
| ▸ | TPSAB1 | Q15661 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | ABL1 | P00519 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | PKM | P14618 | 1/20 | 0.53 |
| ▸ | IDE | P14735 | 1/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16366910 | 1.00 | TDP1 (0.62) | TDP1PLCD1CNR1CA12CA1 | |
| SCHEMBL10044324 | 1.00 | TDP1 (0.62) | TDP1PLCD1CNR1CA12CA1 | |
| SCHEMBL565778 | 1.00 | TDP1 (0.62) | TDP1PLCD1CNR1CA12CA1 | |
| SCHEMBL13165092 | 1.00 | TDP1 (0.62) | TDP1PLCD1CNR1CA12CA1 | |
| SCHEMBL565342 | 1.00 | TDP1 (0.62) | TDP1PLCD1CNR1CA12CA1 | |
| SCHEMBL309059 | 1.00 | TDP1 (0.62) | TDP1PLCD1CNR1CA12CA1 | |
| SCHEMBL10044329 | 1.00 | TDP1 (0.62) | TDP1PLCD1CNR1CA12CA1 | |
| SCHEMBL10140187 | 1.00 | TDP1 (0.62) | TDP1PLCD1CNR1CA12CA1 | |
| SCHEMBL10140259 | 1.00 | TDP1 (0.62) | TDP1PLCD1CNR1CA12CA1 | |
| SCHEMBL1270218 | 1.00 | TDP1 (0.62) | TDP1PLCD1CNR1CA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 92 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119738564-A | Universal anti-AAV 8 antibody ELISA kit and detection method of anti-AAV 8 antibody thereof | 浙江恒驭生物科技有限公司 | 2025-04-01 | — | — | CN | claimed |
| CN-119510773-A | Lentivirus titer detection kit and detection method | 浙江恒驭生物科技有限公司 | 2025-02-25 | — | — | CN | claimed |
| CN-119414015-A | Universal anti-AAV 9 antibody ELISA kit and detection method of anti-AAV 9 antibody thereof | 浙江恒驭生物科技有限公司 | 2025-02-11 | — | — | CN | claimed |
| CN-117330370-A | Adeno-associated virus biotin labeling method | 浙江恒驭生物科技有限公司 | 2024-01-02 | — | — | CN | claimed |
| US-8093367-B2 | Preparation and isolation of 5′ capped mRNA | APPLIED BIOSYSTEMS, LLC (US) | 2012-01-10 | — | — | US | claimed |
| CN-122084605-A | Chemiluminescent detection reagent, composition, kit and method | — | 2026-05-26 | — | — | CN | disclosed |
| CN-122042954-A | Photo-excitation chemiluminescence detection reagent, detection method and application thereof | 科美诊断技术股份有限公司 | 2026-05-15 | — | — | CN | disclosed |
| CN-122042953-A | Photo-excitation chemiluminescence detection method and application thereof | 科美诊断技术股份有限公司 | 2026-05-15 | — | — | CN | disclosed |
| US-20260125703-A1 | ADAPTER-BASED RETROVIRAL VECTOR SYSTEM FOR THE SELECTIVE TRANSDUCTION OF TARGET CELLS | Miltenyi Biotec B.V. & Co. KG (DE) | 2026-05-07 | — | — | US | disclosed |
| EP-4702034-A1 | PSEUDOTYPED RETROVIRAL VECTOR PARTICLE WITH ANTI-CD3 DISPLAY | Miltenyi Biotec B.V. & Co. KG (DE) | 2026-03-04 | — | — | EP | disclosed |
| EP-4702035-A1 | RETROVIRAL VECTOR PARTICLE PSEUDOTYPED WITH ENVELOPE PROTEINS OF CANINE DISTEMPER VIRUS | Miltenyi Biotec B.V. & Co. KG (DE) | 2026-03-04 | — | — | EP | disclosed |
| US-20250333729-A1 | TRINUCLEOTIDE CAP ANALOGS, PREPARATION AND USES THEREOF | Life Technologies Corporation | 2025-10-30 | — | — | US | disclosed |
| WO-1999043287-A2 | PHOSPHATE-BASED DENDRIMERS FOR BIOASSAYS | BIOTRACES, INC. (US) | 1999-09-02 | — | — | WO | disclosed |
| US-5612221-A | Avidin-binding fluorescing and quenching reagent for use in homogeneous assays | DADE CHEMISTRY SYSTEMS INC. (US) | 1997-03-18 | — | — | US | disclosed |
| US-5536820-A | Avidin-binding azo reagents | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1996-07-16 | — | — | US | disclosed |
| US-5512667-A | Trifunctional intermediates for preparing 3'-tailed oligonucleotides | DRUG ROYALTY LP1 (CA) | 1996-04-30 | — | — | US | disclosed |
| US-5419966-A | Solid support for synthesis of 3'-tailed oligonucleotides | MICROPROBE CORPORATION (US) | 1995-05-30 | — | — | US | disclosed |
| EP-0547142-A4 | — | MICROPROBE CORP (US) | 1995-01-18 | — | — | EP | disclosed |
| EP-0547142-A1 | SOLID SUPPORT SYNTHESIS OF 3'-TAILED OLIGONUCLEOTIDES VIA A LINKING MOLECULE | EPOCH PHARMACEUTICALS, INC. (US) | 1993-06-23 | — | — | EP | disclosed |
| WO-1992003464-A1 | SOLID SUPPORT SYNTHESIS OF 3'-TAILED OLIGONUCLEOTIDES VIA A LINKING MOLECULE | MICROPROBE CORPORATION (US) | 1992-03-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250333729-A1 | TRINUCLEOTIDE CAP ANALOGS, PREPARATION AND USES THEREOF | RNGTT, RNMT, CPSF7 | TDP1 420/4885PLCD1 1993/4885CNR1 4614/4885 |
| US-20260125703-A1 | ADAPTER-BASED RETROVIRAL VECTOR SYSTEM FOR THE SELECTIVE TRANSDUCTION OF TARGET CELLS | HAVCR2, PHAX, CD4 | TDP1 3356/4885PLCD1 2867/4885CNR1 4078/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.